Exploring a Meningitis Vaccine for Gonorrhea Prevention

https://www.niaid.nih.gov/news-events/meningitis-vaccine-gonorrhea-prevention?utm_campaign=+60567131&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= A preventive vaccine for gonorrhea would be a major advance in public health, according to an editorial co-authored by NIAID Director Jeanne Marrazzo and Myron Cohen of the University of North Carolina at Chapel Hill. The genetic sequences of the bacteria that cause gonorrhea and meningitis B are closely related. This has led researchers to explore whether the 4CMenB vaccine, approved by the Food and Drug Administration for meningitis B, might also prevent gonorrhea. NIAID is sponsoring an efficacy study of the 4CMenB vaccine for gonorrhea prevention in Malawi, Thailand, and the United States